|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 97, 67-77, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
PO Daily
Patients currently undergoing coronary artery bypass grafting will likely
have worse early and late results because of the selection of patients with
fewer risk factors for percutaneous transluminal coronary angioplasty.
Therefore, until the results of randomized prospective studies are
available, angioplasty should also be compared to bypass grafting before
the era of angioplasty to facilitate current comparison with bypass
grafting. To obtain these data, I analyzed 500 consecutive patients (aged
33 to 79 years [58 +/- 10 SD], 20% [100/500] female, and 60% [300/500] with
three vessel disease) undergoing first-time coronary bypass without
associated procedures between late 1976 and mid-1980. Intermittent aortic
cross-clamping (for each distal graft) was used for revascularization of
all arteries 1.0 mm in internal diameter or larger with stenoses of 50% or
greater. This strategy resulted in complete revascularization in 99.8% of
patients, averaging 3.2 +/- 1.2 distal grafts per patient. The hospital
mortality rate was 0.2% (1/500). The incidence of low output syndrome
necessitating pressors (0.8%) or intraaortic balloon pump support (0.2%)
was 1% (5/500). Perioperative myocardial infarction rate based on new Q
waves was 2.2% (11/500). All but three patients (99.4%) were contacted at 5
years or later with respect to repeat coronary bypass or angioplasty and
survival. The survival rate at 5 years, including hospital deaths, was
92.7% +/- 1.2% (70% confidence limits) for cardiac deaths, 89.8% +/- 1.4%
for all deaths, and 89.8% +/- 1.4% for all deaths plus three patients lost
to follow-up. Approximately 40 factors were screened univariately to
determine their effect on survival and survival free from repeat
intervention. Multivariate analysis revealed, as in other series, that
decreased left ventricular function (ejection fraction less than 50%) was
the predominant determinant of decreased 5-year survival for both cardiac
death and total mortality. At 5 years, the freedom from reintervention was
97.7% +/- 0.7%. Factors associated with repeat intervention were younger
age (52 +/- 11 years versus 58 +/- 10, p less than 0.05) and fewer grafts
(2.3 +/- 1.0 versus 3.3 +/- 1.2, p less than 0.01) because of less severe
disease (three vessel disease 31% versus 60%, p less than 0.05). These
results provide a benchmark for angioplasty which should attain a hospital
mortality rate of under 1%, a periprocedure myocardial infarction rate
under 3%, and a 5-year survival rate of approximately 90% with more than
95% of survivors free of repeat intervention in unselected patients, not
cohorts with primarily single vessel disease.
ARTICLES
Early and five-year results for coronary artery bypass grafting. A benchmark for percutaneous transluminal coronary angioplasty
Donald N. Sharp Memorial Hospital, University of California, San Diego, Medical Center.
This article has been cited by other articles:
![]() |
P. O. Daily, R. K. Freeman, W. P. Dembitsky, R. M. Adamson, R. J. Moreno-Cabral, S. Marcus, and J. A. Lamphere COST REDUCTION BY COMBINED CAROTID ENDARTERECTOMY AND CORONARY ARTERY BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., June 1, 1996; 111(6): 1185 - 1193. [Abstract] [Full Text] |
||||
![]() |
E. Sivertssen, M. Abdelnoor, and N. B. Fjeld Prolonged Aortic Cross-Clamping Time and Cardiopulmonary Bypass Time Have a Gradient Effect on Early Mortality in Open-Heart Surgery Vascular and Endovascular Surgery, March 1, 1995; 29(2): 91 - 97. [Abstract] [PDF] |
||||
![]() |
P. O. Daily, J. A. Lamphere, W. P. Dembitsky, R. M. Adamson, and N. F. Dans Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass graftingA randomized, prospective, double-blind study J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 99 - 108. [Abstract] [Full Text] |
||||
![]() |
R. Seitelberger, W. Hannes, M. Gleichauf, M. Keilich, M. Christoph, R. Fasol, Sponsored by, and E. Wolner Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 811 - 821. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |